PI
VKTX icon

PFG Investments’s Viking Therapeutics VKTX Stock Holding History

PFG Investments’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
6,633
+28
+0.4% +$904 0.01% 1036
2026
Q1 		$215K Sell
6,605
-400
-6% -$12.9K 0.01% 1034
2025
Q4 		$246K Sell
7,005
-925
-12% -$32.8K 0.01% 915
2025
Q3 		$208K Buy
+7,930
New +$237K 0.01% 957
2024
Q4 		– Sell
-3,640
Closed -$230K – 1080
2024
Q3 		$230K Buy
+3,640
New +$214K 0.01% 833
2024
Q2 		– Sell
-4,329
Closed -$355K – 1099
2024
Q1 		$355K Buy
+4,329
New +$193K 0.02% 671

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

PFG Investments's VKTX Position: Q2 2026 in Review

PFG Investments increased its Viking Therapeutics (VKTX) stake by 0.42% in Q2 2026, buying an estimated $904 and bringing the position to 6,633 shares worth $259K. The position accounts for 0.01% of the portfolio, ranked #1036.

PFG Investments first reported a position in VKTX in Q1 2024 and has held it in 6 quarters since. The position peaked at $355K in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • PFG Investments held 6,633 shares of Viking Therapeutics worth $259K as of Q2 2026.
  • PFG Investments bought 28 Viking Therapeutics shares in Q2 2026, an estimated $904.
  • Viking Therapeutics made up 0.01% of PFG Investments's portfolio in Q2 2026, its #1036 holding.
  • PFG Investments first reported a position in Viking Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • PFG Investments's Viking Therapeutics position peaked at $355K in Q1 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.